Stockscreener 앱 받기
11.34
1.70%
0.1606
전일 마감가:
$11.18
열려 있는:
$11.21
하루 거래량:
659.05K
Relative Volume:
0.39
시가총액:
$1.33B
수익:
$260.81M
순이익/손실:
$20.48M
주가수익비율:
87.24
EPS:
0.13
순현금흐름:
$22.67M
1주 성능:
+2.06%
1개월 성능:
+9.54%
6개월 성능:
+16.02%
1년 성능:
-8.45%
1일 변동 폭
$11.17
$11.38
1주일 범위
$10.69
$11.38
52주 변동 폭
$9.20
$14.63
다이나백스 테크놀로지스 Stock (DVAX) Company Profile
명칭
Dynavax Technologies Corp
전화
(510) 848-5100
주소
2100 POWELL STREET, EMERYVILLE, CA
DVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
11.37 | 1.31B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
121.80 | 53.79B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.26 | 45.18B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.95B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.59 | 27.78B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
472.56 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
다이나백스 테크놀로지스 Stock (DVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-02-01 | 개시 | Goldman | Neutral |
| 2022-09-27 | 개시 | JMP Securities | Mkt Outperform |
| 2022-01-06 | 재개 | Goldman | Buy |
| 2021-08-06 | 개시 | Goldman | Buy |
| 2020-08-07 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-15 | 개시 | Evercore ISI | Outperform |
| 2019-10-18 | 개시 | H.C. Wainwright | Buy |
| 2019-07-11 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-05-10 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-03-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-09-25 | 재확인 | RBC Capital Mkts | Outperform |
| 2017-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-07-31 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-07-31 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 개시 | RBC Capital Mkts | Outperform |
| 2013-11-25 | 업그레이드 | MLV & Co | Hold → Buy |
| 2013-02-25 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2012-11-16 | 재확인 | MLV & Co | Buy |
모두보기
다이나백스 테크놀로지스 주식(DVAX)의 최신 뉴스
Dynavax Technologies Corp (DYF1.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporatio (DVAX) Stock forecasts - Yahoo Finance UK
Dynavax Technologies Corporation (0IDA.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Dynavax Technologies Corporation (DYF1) stock a defensive play amid uncertainty2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dynavax (Nasdaq: DVAX) to Join Evercore Healthcare Conference Fireside Chat on Dec. 2 - Stock Titan
Why Dynavax Technologies Corporation (DYF1) stock remains top ratedRate Hike & Low Risk Entry Point Tips - newser.com
Can Dynavax Technologies Corporation stock deliver consistent earnings growthWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Is Dynavax Technologies Corporation showing signs of accumulation2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Why Dynavax Technologies Corporation (DYF1) stock fits value portfoliosTake Profit & Technical Pattern Based Buy Signals - newser.com
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Can Dynavax Technologies Corporation stock reach $100 price targetSell Signal & Smart Allocation Stock Tips - newser.com
How Dynavax Technologies Corporation stock responds to policy changesWeekly Market Report & Low Drawdown Momentum Ideas - newser.com
Vaxart, Inc. Enters Exclusive License Agreement with Dynavax for COVID-19 Oral Vaccine Candidate, Completes Phase 2b Enrollment and Reports Q3 2025 Financial Results - Quiver Quantitative
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance
What institutional flow reveals about Dynavax Technologies CorporationWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Is Dynavax Technologies Corporation (DYF1) stock protected from inflationJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockInflation Watch & Verified Technical Signals - newser.com
What analysts say about Dynavax Technologies Corporation DYF1 stockDividend Growth Stocks & Trusted Financial Advisors at No Cost - earlytimes.in
What MACD and RSI say about Dynavax Technologies CorporationDollar Strength & Growth Focused Investment Plans - newser.com
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2025 Earnings Call Transcript - Insider Monkey
Why Dynavax Technologies (DVAX) Is Up 5.7% After Launching a $100 Million Buyback and Raising Guidance - Yahoo Finance
Dynavax targets 60% U.S. hepatitis B market share by 2030 amid new COVID-19 vaccine deal and expanded share repurchase - MSN
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favoriteWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Dynavax posts 13% rise in HEPLISAV-B revenue, announces $100 million buyback - Investing.com Nigeria
Dynavax Technologies: Q3 Earnings Snapshot - ctinsider.com
다이나백스 테크놀로지스 (DVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다이나백스 테크놀로지스 주식 (DVAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
6.14%
1.83%
자본화:
|
볼륨(24시간):